"One All" to Get it RYT (Resilient Young Tribal Adults)
Launched by UNIVERSITY OF PITTSBURGH · Jun 18, 2024
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "One All" to Get it RYT, is focused on improving mental health and resilience among young tribal adults through a sports-based program using Ultimate Frisbee. The study is taking place in two locations in South India: Gudalur in Tamil Nadu and BR Hills in Karnataka. The main goal is to see how well this program works and how acceptable it is for young people in these communities. Researchers will train facilitators to lead the program and will check its effectiveness at two points in time, 12 months and 18 months after starting.
To be eligible for this trial, participants must be members of the tribal communities where the study is being conducted. Unfortunately, non-tribal individuals and those who join the program after the initial assessments will not be included. Participants can expect to engage in the Ultimate Frisbee program and share their experiences through discussions. Overall, this study aims to create a supportive environment for young people to build resilience and improve their mental well-being through sports and community involvement.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants who are tribals and are recruited for One-all intervention
- Exclusion Criteria:
- • All participants who are recruited for One-all intervention, but, are nottribals.
- • ii. Any child joining the programme subsequently after the baseline measuresare taken and the first session is delivered will not be recruited.
- • iii. If a participant is not fluent in any of the languages listed, they will not beable to participate in the research study.
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chamaraja Nagar, Karnataka, India
Gudalur, Tamilnadu, India
Patients applied
Trial Officials
Vishwajit Nimgaonkar, MD, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported